NCT02532114
- Conditions
- Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Genital Diseases, +12 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Castration Levels of Testosterone
Explore clinical trials studying Castration Levels of Testosterone. Study availability and eligibility vary by location and protocol.
13 public trials
1 recruiting study
Castration Levels of Testosterone trial results
Active, Not Recruiting
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
NCT03419234
- Conditions
- Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Genital Diseases, +12 more
- Locations
-
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- Kingman Regional Medical Center Kingman, Arizona, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
Active, Not Recruiting
Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
NCT02703623
- Conditions
- Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Genital Diseases, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- MD Anderson in Katy Houston, Texas, United States
- MD Anderson in Sugar Land Sugar Land, Texas, United States